Register
SEC Form 4 insider trading filings tracked in real time from EDGAR

Deschatelets Pascal — Chief Scientific Officer

Insider trading activity for Deschatelets Pascal sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Scientific Officer
  • Company: Apellis Pharmaceuticals, Inc.
  • Total insider trades: 22
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 14, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 9,805 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 30,845 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 45,000 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 56,250 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 50,974 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 95,000 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 110,000 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 82,500 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 108,622 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 25,840 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 11,284 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 3,372 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 4,909 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 25,840 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. BUY 25,840 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 12,920 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. BUY 12,920 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 10,030 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. BUY 10,030 N/A
May 14, 2026 Deschatelets Pascal APLS Apellis Pharmaceuticals, Inc. SELL 41,250 N/A

← All executives · Full trades feed